Lundbeck Expands EVERSANA AI Commercialization | Lucid Diligence Brief
Lundbeck Expands EVERSANA AI Across Its U.S. Commercial Organization…
Neuroscience Strategic Roundup | July 21–August 25, 2026
Neuroscience Strategic Roundup exploring Key Strategic Developments and…
Endocrinology Strategic Roundup | July 21–August 24, 2026
Endocrinology Strategic Roundup exploring Key Strategic Developments and…
Public Health Strategic Roundup | July 16–August 20, 2026
Public Health Strategic Roundup: Key Developments, Trends and Strategic…
Insulinova Partners with Ospedale San Raffaele | Lucid Diligence Brief
Avaí Bio and Insulinova Test Encapsulated Beta Cells With San Raffaele as…
Oncology Strategic Roundup | July 02 – Aug 07, 2026
Oncology Strategic Roundup exploring Developments and Competitive Shifts…
Genprex Roche Diagnostics TROP2 Collaboration | Lucid Diligence Brief
Genprex and Roche Diagnostics begin TROP2 assay validation to support…
Johnson & Johnson Firefly Bio Acquisition | Lucid Diligence Brief
Johnson & Johnson's $1 billion Firefly Bio acquisition highlights a…
Harbour BioMed and Sinopharm Innovation Consortium Expands Biologics Strategy | Lucid Diligence Brief
Harbour BioMed partners with Sinopharm to establish an innovation consortium…
Evogene and ELEO Oral PCSK9 Collaboration | Lucid Diligence Brief
Evogene and ELEO Oral PCSK9 discovery collaboration launches as Merck’s…
Excalipoint Therapeutics and DP Technology Partnership | Lucid Diligence Brief
Excalipoint Therapeutics and DP Technology have partnered to develop an agentic…
Nucleai-University of Glasgow Partnership Expands Spatial AI Platform | Lucid Diligence Brief
Nucleai broadened its University of Glasgow collaboration to expand academic…